SOP for genomic data encryption – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Fri, 10 Oct 2025 17:45:18 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Genomic Data Handling and Biobanking Governance https://www.clinicalstudies.in/sop-for-genomic-data-handling-and-biobanking-governance/ Fri, 10 Oct 2025 17:45:18 +0000 ]]> https://www.clinicalstudies.in/?p=7066 Read More “SOP for Genomic Data Handling and Biobanking Governance” »

]]>
SOP for Genomic Data Handling and Biobanking Governance

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-genomic-data-handling-and-biobanking-governance”
},
“headline”: “SOP for Genomic Data Handling and Biobanking Governance”,
“description”: “This SOP defines procedures for handling genomic data and managing biobanks in clinical trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements while safeguarding subject privacy, data security, and ethical governance of biobanking activities.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Genomic Data Handling and Biobanking Governance

SOP No. CR/OPS/126/2025
Supersedes NA
Page No. 1 of 74
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to define standardized procedures for the collection, handling, storage, analysis, and governance of genomic data and biobanked samples in clinical trials. This ensures regulatory compliance, ethical oversight, subject privacy, and integrity of genetic research data.

Scope

This SOP applies to sponsors, investigators, biobank managers, CROs, laboratory staff, data managers, and regulatory affairs personnel involved in genomic data and biobanking governance. It covers consent, data acquisition, storage, transfer, analysis, quality control, archiving, and inspection readiness.

Responsibilities

  • Sponsor: Ensures ethical and compliant genomic data collection and biobank governance.
  • Investigator: Obtains informed consent for genomic studies and sample use.
  • Biobank Manager: Oversees secure sample storage and access control.
  • Laboratory Staff: Processes genomic samples under validated procedures.
  • CRO: Monitors genomic data collection and biobank compliance.
  • QA: Conducts audits on genomic data handling and governance procedures.
  • Data Protection Officer: Ensures GDPR/HIPAA compliance for genomic data privacy.

Accountability

The Sponsor’s Genomic Program Lead is accountable for governance of genomic data and biobanking processes. Biobank Managers are accountable for sample integrity and security at storage facilities.

Procedure

1. Informed Consent for Genomic Data
1.1 Obtain subject consent for genomic sample collection and data use.
1.2 Include rights for withdrawal of genomic data.
1.3 Record in Genomic Consent Log (Annexure-1).

2. Sample Collection and Handling
2.1 Collect samples under validated procedures.
2.2 Use anonymization or pseudonymization for identifiers.
2.3 Record in Sample Collection Log (Annexure-2).

3. Biobank Storage and Security
3.1 Store samples in validated biobank facilities with environmental monitoring.
3.2 Control access to authorized personnel only.
3.3 Document in Biobank Storage Log (Annexure-3).

4. Genomic Data Handling
4.1 Process data using validated bioinformatics pipelines.
4.2 Encrypt data during transfer and storage.
4.3 Record in Genomic Data Handling Log (Annexure-4).

5. Data Privacy and Security
5.1 Comply with GDPR, HIPAA, and regional privacy rules.
5.2 Maintain subject confidentiality at all stages.
5.3 Document in Data Privacy Compliance Log (Annexure-5).

6. Quality Assurance
6.1 Perform quality checks on genomic data and biobank records.
6.2 Record in QA Log (Annexure-6).

7. Data Sharing and Transfer
7.1 Share genomic data with regulators/repositories under approved agreements.
7.2 Maintain Data Transfer Log (Annexure-7).

8. Archiving
8.1 Archive genomic data and sample records in TMF and ISF.
8.2 Retain per regulatory timelines (minimum 25 years in EU).

Abbreviations

  • SOP: Standard Operating Procedure
  • CRO: Contract Research Organization
  • QA: Quality Assurance
  • HIPAA: Health Insurance Portability and Accountability Act
  • GDPR: General Data Protection Regulation
  • ISF: Investigator Site File
  • TMF: Trial Master File
  • FDA: Food and Drug Administration
  • EMA: European Medicines Agency
  • CDSCO: Central Drugs Standard Control Organization
  • WHO: World Health Organization

Documents

  1. Genomic Consent Log (Annexure-1)
  2. Sample Collection Log (Annexure-2)
  3. Biobank Storage Log (Annexure-3)
  4. Genomic Data Handling Log (Annexure-4)
  5. Data Privacy Compliance Log (Annexure-5)
  6. QA Log (Annexure-6)
  7. Data Transfer Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Genomic Data Specialist
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Genomic Consent Log

Date Subject ID Consent Obtained Investigator Status
01/09/2025 G101 Yes PI Signed

Annexure-2: Sample Collection Log

Date Subject ID Sample Type Collected By Status
02/09/2025 G101 Blood Lab Staff Processed

Annexure-3: Biobank Storage Log

Date Sample ID Storage Location Temperature Status
03/09/2025 SB-101 Freezer-01 -80°C Stored

Annexure-4: Genomic Data Handling Log

Date Dataset Handled By Activity Status
04/09/2025 G101-RNA Data Manager Processed Validated

Annexure-5: Data Privacy Compliance Log

Date System Privacy Measure Reviewed By Status
05/09/2025 Biobank Database Encryption + Pseudonymization DPO Compliant

Annexure-6: QA Log

Date Activity Auditor Outcome
06/09/2025 Biobank Sample Audit QA Officer Compliant

Annexure-7: Data Transfer Log

Date Dataset Transferred To Method Status
07/09/2025 G101-RNA Regulatory Repository Secure FTP Transferred

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Operations

For more SOPs visit: Pharma SOP

]]>